Video Experimental Relacionado
Updated: Jul 8, 2026
14:32
Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
Published on: January 28, 2013
Inhibición dendrodendrítica a través de la reversión del transporte de la dopamina
B H Falkenburger1, K L Barstow, I M Mintz
1Department of Pharmacology and Experimental Therapeutics, Boston University Medical Center, Boston, MA 02118, USA.
Science (New York, N.Y.)
|September 29, 2001
Resumen
Los investigadores descubrieron una nueva forma de autoinhibición en el cerebro. El bloqueo del transportador de dopamina impidió la liberación de dopamina, lo que sugiere la liberación mediada por el transportador, no la exocitosis, para esta comunicación neuronal.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Biología celular Biología celular.
Sus antecedentes:
- Las sinapsis del sistema nervioso central tradicionalmente incluyen exocitosis presináptica y estructuras postsinápticas.
- La comunicación dendrodendrítica, donde las dendritas interactúan, se entiende menos con respecto a sus mecanismos de liberación.
Objetivo del estudio:
- Para investigar el mecanismo de la inhibición dendrodendrítica en la sustancia negra.
- Para determinar si la liberación de dopamina en este contexto se produce a través de la exocitosis convencional o una vía alternativa.
Principales métodos:
- Utilizó grabaciones amperométricas y de pinzas de parche en rebanadas de cerebro de rata.
- Investigó los efectos del bloqueo del transportador de dopamina en la liberación de dopamina dendrítica y la inhibición neuronal.
Principales resultados:
- El bloqueo del transportador de dopamina eliminó la liberación de dopamina dendrítica y la subsecuente autoinhibición.
- Se demostró que la autoinhibición dendrodendrítica se basa en la liberación de dopamina mediada por el transportista, distinta de la exocitosis.
Conclusiones:
- La autoinhibición dendrodendrítica en la sustancia negra está mediada por la liberación de dopamina impulsada por el portador, no por la exocitosis.
- Este hallazgo sugiere posibles aplicaciones terapéuticas para los inhibidores del transportador de dopamina, como ciertos antidepresivos, en la enfermedad de Parkinson temprana.
Videos de Conceptos Relacionados
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...